Ionis Pharmaceuticals Other Long Term Assets (Quarterly) Analysis

Ionis Pharmaceuticals, Inc. (IONS)

78.45 +0.92 (+1.19%) USD | NASDAQ | Jan 21, 09:51

View Other Long Term Assets (Quarterly) for IONS.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Long Term Assets (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Long Term Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Long Term Assets (Quarterly) Benchmarks

Start Trial

Eli Lilly & Co.	Upgrade
Pfizer Inc.	Upgrade
Alnylam Pharmaceuticals, Inc.	Upgrade
Biogen, Inc.	Upgrade
Cogent Biosciences, Inc.	Upgrade